Search

everythinglearnresearchcommunity

for

Search:↓

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

People with hair loss often have lower levels of zinc and copper in their blood.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Women with PCOS often have more sleep problems than the general population.

Early hair loss may be linked to metabolic syndrome.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Minoxidil helps protect and rebuild elastic fibers in arteries, improving artery function, especially in older females.

Higher hair calcium to magnesium ratios and lower chromium levels in hair may indicate insulin resistance in Korean men.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Higher alarin levels might link hair loss and metabolic syndrome.

Obesity can worsen wound healing by negatively affecting the function of stem cells in fat tissue.

Classical PCOS types A and B are most common and linked to higher health risks.

Hair loss may indicate higher heart risk and metabolic issues.